🧪
hypothesis

protective chromatin remodeling defines the therapeutic window for: Are DNA methylation changes in neurodegeneration causal drivers or protective cons

Hypothesis

protective chromatin remodeling defines the therapeutic window for: Are DNA methylation changes in neurodegeneration causal drivers or protective cons

The same signal may be beneficial early and damaging late.
🧬 protective chromatin remodeling🩺 neurodegeneration🎯 Composite 35%💱 $0.48▼27.1%active
EvidencePending (0%)📖 6 cit🗣 1 debates 6 support 1 oppose
✓ All Quality Gates Passed
☰ Compare⚔️ Duel⚛️ Collide
📄 Export LaTeX
arXiv PreprintNeurIPSNature MethodsPLOS ONE
📖 Export BibTeXinteract with this hypothesis
Composite35%

🧪 Overview

The same signal may be beneficial early and damaging late. Testing protective chromatin remodeling with single-cell methylome tracking should reveal a disease-stage interaction and define when intervention is protective versus counterproductive.

🧬 Mechanism

🧬 Curated Mechanism Pathway

Curated pathway from expert analysis

flowchart TD
    A["Protective Chromatin Remodeling<br/>Early Stress-Adaptive State"]
    B["H3K27ac Gain at Defense Loci<br/>NRF2 and FOXO3 Target Activation"]
    C["H3K9me3 Deployment<br/>Transposon and Repeat Silencing"]
    D["Stage-Dependent Transition<br/>Adaptive to Pathological Shift"]
    E["Late-Stage Heterochromatin Loss<br/>Progressive Chromatin Collapse"]
    F["Early Intervention Window<br/>Chromatin Reinforcement Strategy"]
    G["Epigenome Targeting Therapy<br/>HDAC Inhibitor or DNMT Modulator"]
    A --> B
    A --> C
    B --> D
    C --> D
    D --> E
    F -.->|"extends"| A
    G -.->|"implements"| F
    style A fill:#1a237e,stroke:#4fc3f7,color:#4fc3f7
    style D fill:#7b1fa2,stroke:#ce93d8,color:#ce93d8
    style E fill:#b71c1c,stroke:#ef9a9a,color:#ef9a9a
    style G fill:#1b5e20,stroke:#81c784,color:#81c784

⚖️ Evidence

⚖️ Evidence Matrix5 supports1 contradicts
Supports
TDP-43 Triggers Mitochondrial DNA Release via mPTP to Activate cGAS/STING in ALS.
Cell2020PMID:33031745medium
Supports
DNA Damage, Neurodegeneration, and Synaptic Plasticity.
Neural Plast2016PMID:27313899medium
Supports
Human endogenous retrovirus-K contributes to motor neuron disease.
Sci Transl Med2015PMID:26424568medium
Supports
Premature polyadenylation-mediated loss of stathmin-2 is a hallmark of TDP-43-dependent neurodegeneration.
Nat Neurosci2019PMID:30643298medium
Supports
WDR45 contributes to neurodegeneration through regulation of ER homeostasis and neuronal death.
Autophagy2020PMID:31204559medium
Contradicts
causal direction requires longitudinal perturbation
skeptic_round
📖 Linked Papers (10)Export BibTeX ↗
TDP-43 Triggers Mitochondrial DNA Release via mPTP to Activate cGAS/STING in ALS.
Cell (2020) · PubMed:33031745 ↗
12 figures
Figure 1
Figure 1
No caption available
Figure S1
Figure S1
Elevated NF-κB and Type I IFN Signaling Because of TDP-43 In Vitro , Related to Figure 1 (A) Doxycycline (Dox inducible wild-type (WT) or ALS mutant (Q331K) T...
TDP-43 Triggers Mitochondrial DNA Release via mPTP to Activate cGAS/STING in ALS.
Cell (2020) · PubMed:33031745 ↗
No figures
WDR45 contributes to neurodegeneration through regulation of ER homeostasis and neuronal death.
Autophagy (2020) · PubMed:31204559 ↗
No figures
WDR45 contributes to neurodegeneration through regulation of ER homeostasis and neuronal death.
Autophagy (2020) · PubMed:31204559 ↗
No figures
Premature polyadenylation-mediated loss of stathmin-2 is a hallmark of TDP-43-dependent neurodegeneration.
Nature neuroscience (2019) · PubMed:30643298 ↗
No figures
Premature polyadenylation-mediated loss of stathmin-2 is a hallmark of TDP-43-dependent neurodegeneration.
Nature neuroscience (2019) · PubMed:30643298 ↗
No figures
DNA Damage, Neurodegeneration, and Synaptic Plasticity.
Neural plasticity (2018) · PubMed:27313899 ↗
No figures
DNA Damage, Neurodegeneration, and Synaptic Plasticity.
Neural Plast (2016) · PubMed:27313899 ↗
No figures
Human endogenous retrovirus-K contributes to motor neuron disease.
Science translational medicine (2015) · PubMed:26424568 ↗
No figures
Human endogenous retrovirus-K contributes to motor neuron disease.
Science translational medicine (2015) · PubMed:26424568 ↗
No figures

🏥 Translation

🧬 3D Protein Structure — PROTECTIVE

No curated PDB or AlphaFold mapping for PROTECTIVE yet. Search RCSB →

💉 Clinical Trials

No clinical trials data linked to this hypothesis yet.

No curated ClinVar variants loaded for this hypothesis.

Run scripts/backfill_clinvar_variants.py to fetch P/LP/VUS variants.

🔍 Search ClinVar for protective chromatin remodeling →

No DepMap CRISPR Chronos data found for protective chromatin remodeling.

Run python3 scripts/backfill_hypothesis_depmap.py to populate.

🏆 Tournament

🏆 Arenas / Elo

No arena matches recorded yet. Browse Arenas →

📊 Market Indicators

7d Trend
Stable
7d Momentum
▲ 0.0%
Volatility
High
0.2317
Events (7d)
0
Price History
▼27.1%

💾 Resource Usage

No resource usage or linked notebooks recorded for this hypothesis yet.

🔮 Predictions

🔎 Predictions vs Observations2 predictions · 0 with recorded observations
PredictionPredictedObservedStatusConf
IF the remodeling is protective rather than pathological, THEN individuals with higher baseline protective chromatin signatures will show >=15% slower NfL increase over 2 years despite comparable baseTop-quartile protective signature predicts >=15% lower annual plasma NfL slope than bottom quartile.— no observation —pending0.49
IF protective chromatin remodeling defines the therapeutic window, THEN enhancing the remodeling program before stress will improve neuronal survival by >=20%, whereas the same enhancement after injurPre-stress enhancement yields >=20% survival benefit and post-injury enhancement yields <5% benefit.— no observation —pending0.54
🔮 Falsifiable Predictions (2)
pendingconf 54%
IF protective chromatin remodeling defines the therapeutic window, THEN enhancing the remodeling program before stress will improve neuronal survival by >=20%, whereas the same enhancement after injury onset will improve survival by <5%.
Predicted outcome: Pre-stress enhancement yields >=20% survival benefit and post-injury enhancement yields <5% benefit.
Falsification: Timing does not modify response or late enhancement is equally protective.
pendingconf 49%
IF the remodeling is protective rather than pathological, THEN individuals with higher baseline protective chromatin signatures will show >=15% slower NfL increase over 2 years despite comparable baseline pathology.
Predicted outcome: Top-quartile protective signature predicts >=15% lower annual plasma NfL slope than bottom quartile.
Falsification: NfL slopes differ by <5% or top-quartile participants decline faster.
View on SciDEX ↗